Ureadepsipeptides as ClpP Activators
Journal Article
·
· ACS Infectious Diseases
- St. Jude Children’s Research Hospital, Memphis, TN (United States)
- Northeastern Univ., Boston, MA (United States)
- Arietis Pharma, Boston, MA (United States)
Acyldepsipeptides are a unique class of antibiotics that act via allosterically dysregulated activation of the bacterial caseinolytic protease (ClpP). The ability of ClpP activators to kill nongrowing bacteria represents a new opportunity to combat deep-seated biofilm infections. However, the acyldepsipeptide scaffold is subject to rapid metabolism. In this study, we explore alteration of the potentially metabolically reactive α,β unsaturated acyl chain. Through targeted synthesis, a new class of phenyl urea substituted depsipeptide ClpP activators with improved metabolic stability is described. The ureadepsipeptides are potent activators of Staphylococcus aureus ClpP and show activity against Gram-positive bacteria, including S. aureus biofilms. These studies demonstrate that a phenyl urea motif can successfully mimic the double bond, maintaining potency equivalent to acyldepsipeptides but with decreased metabolic liability. Although removal of the double bond from acyldepsipeptides generally has a significant negative impact on potency, structural studies revealed that the phenyl ureadepsipeptides can retain potency through the formation of a third hydrogen bond between the urea and the key Tyr63 residue in the ClpP activation domain. Ureadepsipeptides represent a new class of ClpP activators with improved drug-like properties, potent antibacterial activity, and the tractability to be further optimized.
- Research Organization:
- Advanced Photon Source (APS), Argonne National Laboratory (ANL), Argonne, IL (US)
- Sponsoring Organization:
- National Institutes of Health (NIH); USDOE Office of Science (SC), Basic Energy Sciences (BES)
- Grant/Contract Number:
- W-31109-ENG-38
- OSTI ID:
- 1575009
- Journal Information:
- ACS Infectious Diseases, Journal Name: ACS Infectious Diseases Journal Issue: 11 Vol. 5; ISSN 2373-8227
- Publisher:
- American Chemical Society (ACS)Copyright Statement
- Country of Publication:
- United States
- Language:
- ENGLISH
Similar Records
Activated ClpP kills persisters and eradicates a chronic biofilm infection.
Acyldepsipeptide Antibiotics Induce the Formation of a Structured Axial Channel in ClpP: A Model for the ClpX/ClpA-Bound State of ClpP
In Vivo and In Vitro Effects of a ClpP-Activating Antibiotic against Vancomycin-Resistant Enterococci
Journal Article
·
Wed Nov 20 23:00:00 EST 2013
· Nature, 503(7476):365-370
·
OSTI ID:1130671
Acyldepsipeptide Antibiotics Induce the Formation of a Structured Axial Channel in ClpP: A Model for the ClpX/ClpA-Bound State of ClpP
Journal Article
·
Thu Dec 31 23:00:00 EST 2009
· Chemistry and Biology
·
OSTI ID:1019727
In Vivo and In Vitro Effects of a ClpP-Activating Antibiotic against Vancomycin-Resistant Enterococci
Journal Article
·
Mon May 21 00:00:00 EDT 2018
· Antimicrobial Agents and Chemotherapy
·
OSTI ID:1479031